Literature DB >> 2860689

Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.

J Arnt, J Hyttel.   

Abstract

The antagonistic effect of dopamine (DA) D-1 and D-2 antagonists against circling behaviour induced by various DA agonists in 6-OHDA-lesioned rats has been investigated. DA D-1/D-2 selectivity of agonists in vitro was measured by the stimulatory effect on DA-sensitive adenylate cyclase in rat striatal homogenates (D-1), the inhibitory effect on electrically-induced release of 3H-DA in rabbit striatal slices (D-2) and the affinity to 3H-piflutixol (D-1) and 3H-spiroperidol (D-2) binding sites in rat striatal membranes. The contralateral circling behaviour induced by the DA D-1 agonist SK & F 38393 was blocked by the DA D-1 antagonist, SCH 23390, and by the mixed DA D-1/D-2 antagonist cis(Z)-flupentixol, but was not influenced by the DA D-2 antagonists spiroperidol and clebopride. In contrast, circling behaviour induced by the preferential DA D-2 agonists pergolide and LY 171555 was blocked by clebopride, spiroperidol, and cis(Z)-flupentixol, but weakly or not influenced by SCH 23390. Apomorphine-induced circling behaviour was blocked by cis(Z)-flupentixol, partially antagonized by SCH 23390 and clebopride but not inhibited by spiroperidol, although the time-course of circling was changed. Combinations of SCH 23390 with spiroperidol or clebopride in low doses completely blocked the effect of apomorphine. These results indicate that DA D-1 and D-2 receptors mediate circling behaviour through separate mechanisms which can be independently manipulated with respective agonists and antagonists.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860689     DOI: 10.1007/bf00428200

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.

Authors:  B Costall; R J Naylor; C Pycock
Journal:  Eur J Pharmacol       Date:  1976-02       Impact factor: 4.432

3.  Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro.

Authors:  J Hyttel
Journal:  Life Sci       Date:  1981-02-02       Impact factor: 5.037

4.  Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum.

Authors:  J C Stoof; J W Kebabian
Journal:  Brain Res       Date:  1982-11-04       Impact factor: 3.252

5.  Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.

Authors:  J Arnt; J Hyttel
Journal:  Eur J Pharmacol       Date:  1984-07-13       Impact factor: 4.432

6.  Further evidence that 3H-cis(Z)flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum.

Authors:  J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

7.  Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus.

Authors:  K Starke; L Späth; J D Lang; C Adelung
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

8.  Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats.

Authors:  R W Fuller; S K Hemrick-Luecke; D T Wong; D Pearson; P G Threlkeld; M D Hynes
Journal:  J Pharmacol Exp Ther       Date:  1983-11       Impact factor: 4.030

9.  Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat.

Authors:  S Fleminger; H van de Waterbeemd; N M Rupniak; C Reavill; B Testa; P Jenner; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1983-06       Impact factor: 3.765

10.  Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.

Authors:  J Lehmann; M Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1983-03-18       Impact factor: 4.432

View more
  22 in total

1.  Effect of pergolide on endogenous and exogenous L-DOPA metabolism in the rat striatum: a microdialysis study.

Authors:  S Dethy; M A Laute; A Luxen; J Hildebrand; S Goldman
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Apomorphine response plasticity in lesioned rats: supersensitivity dependency and lack of drug- or non-drug-associated environmental cuing.

Authors:  D M Coward
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists.

Authors:  T S Shippenberg; R Bals-Kubik; A Huber; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 4.  Parkinson's disease.

Authors:  E C Wolters; D B Calne
Journal:  CMAJ       Date:  1989-03-01       Impact factor: 8.262

5.  In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.

Authors:  S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

6.  Chronic levodopa impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting.

Authors:  D M Yurek; K Steece-Collier; T J Collier; J R Sladek
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

7.  Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson disease.

Authors:  Ho-Joo Lee; Richard P Bazinet; Stanley I Rapoport; Abesh Kumar Bhattacharjee
Journal:  Neurochem Res       Date:  2009-12-08       Impact factor: 3.996

8.  Morphine withdrawal aggression: modification with D1 and D2 receptor agonists.

Authors:  J W Tidey; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.

Authors:  J Hyttel; J Arnt
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

10.  Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses.

Authors:  J D Winkler; K Thermos; B Weiss
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.